Immunotherapy injected into spinal fluid for lung cancer that has spread to the brain lining
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This trial tests giving an immunotherapy drug directly into the spinal fluid for people with non-small cell lung cancer that has spread to the lining of the brain or spinal cord. The goal is to see if this approach can help control the cancer while allowing you to continue other treatments you may already be taking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have non-small cell lung cancer that has spread to the lining of the brain or spinal cord (called leptomeningeal metastases).
- You are able to get around and take care of yourself, even if you need some help (ECOG score 0 to 4).
- Your doctor expects you to live at least 4 more weeks.
- You have adequate organ function, including normal blood counts, kidney function, and liver function.
- You are willing to use birth control if needed, and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of low-dose radiation to the whole brain, immunotherapy, and chemotherapy given through a lumbar puncture. It is for people with lung cancer that has spread to the lining of the brain and has not responded to standard treatments.
This trial tests a drug called pemetrexed, given directly into the fluid around the spinal cord (intrathecal), for people with lung cancer that has spread to the brain and spinal cord lining and is no longer controlled by the targeted therapy osimertinib.
This trial tests a new way of giving an experimental drug directly into the fluid around the brain and spinal cord for people whose lung cancer has spread there and stopped responding to targeted therapy. The goal is to see if it can shrink or control the cancer in this area and help with symptoms.
This study tests a treatment called intrathecal pemetrexed, which is chemotherapy given directly into the fluid around your brain and spine. It's for people with a specific type of lung cancer that has spread to the lining of the brain or spinal cord after targeted therapy stopped working.
This trial tests a treatment given directly into the fluid around the brain and spinal cord (intrathecal injection) using two drugs—pemetrexed and bevacizumab—for people with non-small cell lung cancer that has spread to that area (leptomeningeal metastases). It may be an option if your current treatment is no longer working.
This study tests whether giving a higher dose of an EGFR-targeted pill, either alone or with a chemotherapy drug injected into the fluid around the spinal cord, can control lung cancer that has spread to the lining of the brain (called leptomeningeal metastases). It is for people whose cancer has gotten worse in the brain lining while on a standard dose of this type of medication.
Hear when a new NSCLC Associated With Leptomeningeal Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.